Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Chan

Showing results (81-90 of 164) with videos related to

Pageof 17
Sort By:
Cancer|October 12, 2013
Intermittent versus continuous erlotinib with concomitant modified "XELOX" (q3W) in first-line treatment of metastatic colorectal cancer: correlation with serum amphiregulin and transforming growth factor alphaBrigette B Y Ma, Stephen L Chan, Wing M Ho, et al.
British Journal of Cancer|January 27, 2017
Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasionImam Waked, Sarah Berhane, Hidenori Toyoda, et al.
Cancer Letters|November 5, 2021
Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesisFeng Wu, Liangliang Xu, Yalin Tu, et al.
Journal of Gastroenterology and Hepatology|January 26, 2011
Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian populationStephen L Chan, Frankie K F Mo, Philip J Johnson, et al.
Journal of Gastroenterology and Hepatology|July 1, 2020
Endoscopic ultrasound-guided cyanoacrylate injection to prevent rebleeding in hepatocellular carcinoma patients with variceal hemorrhageRaymond S Y Tang, Moe H Kyaw, Anthony Y B Teoh, et al.
Hepatology (Baltimore, Md.)|June 1, 2007
Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapyWinnie Yeo, Frankie K F Mo, Stephen L Chan, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 27, 2007
The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomasStephen L Chan, Yan Cui, Andrew van Hasselt, et al.
Theranostics|March 21, 2018
Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic featuresXiangchun Li, Weiqi Xu, Wei Kang, et al.
Nature Reviews. Clinical Oncology|June 10, 2026
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statementJosep M Llovet, Ezequiel Mauro, Lorenza Rimassa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2014
Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI gradePhilip J Johnson, Sarah Berhane, Chiaki Kagebayashi, et al.
Pageof 17

Showing results (81-90 of 164) with videos related to

Sort By:
Pageof 17
Cancer|October 12, 2013
Intermittent versus continuous erlotinib with concomitant modified "XELOX" (q3W) in first-line treatment of metastatic colorectal cancer: correlation with serum amphiregulin and transforming growth factor alphaBrigette B Y Ma, Stephen L Chan, Wing M Ho, et al.
British Journal of Cancer|January 27, 2017
Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasionImam Waked, Sarah Berhane, Hidenori Toyoda, et al.
Cancer Letters|November 5, 2021
Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesisFeng Wu, Liangliang Xu, Yalin Tu, et al.
Journal of Gastroenterology and Hepatology|January 26, 2011
Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian populationStephen L Chan, Frankie K F Mo, Philip J Johnson, et al.
Journal of Gastroenterology and Hepatology|July 1, 2020
Endoscopic ultrasound-guided cyanoacrylate injection to prevent rebleeding in hepatocellular carcinoma patients with variceal hemorrhageRaymond S Y Tang, Moe H Kyaw, Anthony Y B Teoh, et al.
Hepatology (Baltimore, Md.)|June 1, 2007
Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapyWinnie Yeo, Frankie K F Mo, Stephen L Chan, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 27, 2007
The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomasStephen L Chan, Yan Cui, Andrew van Hasselt, et al.
Theranostics|March 21, 2018
Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic featuresXiangchun Li, Weiqi Xu, Wei Kang, et al.
Nature Reviews. Clinical Oncology|June 10, 2026
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statementJosep M Llovet, Ezequiel Mauro, Lorenza Rimassa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2014
Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI gradePhilip J Johnson, Sarah Berhane, Chiaki Kagebayashi, et al.
Pageof 17